myeloma
-
Weizmann Institute of Science, TASMC conduct genetic study on multiple myeloma
Weizmann scientists found out what genetic changes had occurred in the patients’ cancers to make them resistant to the drugs…
Read More » -
Janssen presents data from Phase 1 study of Talquetamab
The drug will be used in the treatment of relapsed or refractory multiple myeloma The Janssen Pharmaceutical Companies of Johnson…
Read More »